>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • COHR +15.3%, MYGN +13.6%, JIVE +10.1%, PSDV +9.6%, MCHP +7.7%, CTSH +5.1%, CNO +4.5%,ALK +4.3%, PIR +3.8%, (reiterates Q4 guidance)
  • CAMT +3.3%, YUMC +3.1%, (also announces $300 mln buyback; promotes KFC CEO to COO), TWLO +2.9%,PNRA +2.7%, SNY +2.2%, EMKR +2.1%
  • IPHI +2.1%, GNW +2%, SYT +1.9%, GRA +1.7%, CALD +1.6%, AGN +1.4%, NUAN +1.3%, FARM +0.5%, LUV +0.5%, ARCH +0.5%, TWX +0.5%
M&A news:
  • TIME +2.1% (Meredith (MDP) and group of investors might move ahead with acquisition of TIME, according to WSJ)
Select metals/mining stocks trading higher:
  • HMY +4%, KGC +2.5%, AG +2.1%, AU +1.7%, GDX +1.4%, NEM +1.2%, GFI +1.1%, ABX +1.1%
Other news:
  • APOP +11.5% (treated the first blood cancer patient in the recently initiated Phase I/II trial of its stem cell technology ApoGraft)
  • GALT +6.3% (announces combination immunotherapy with Galectin-3 inhibitor GR-MD-02 'enhances' effects in pre-clinical models and early results of phase 1 clinical trials; data presented at the GTCBio Immunotherapeutics Conference)
  • CRCM +4.2% (continued strength)
  • HT +3.5% (will replace WCI Communities in the S&P SmallCap 600)
  • CTB +2.6% (will replace comScore in the S&P MidCap 400)
  • EIX +1% (California Utilities' settlement agreement)
Analyst comments:
  • USAK +3% (upgraded to Mkt Perform from Mkt Underperform at Avondale)
  • TWTR +2.4% (upgraded to Buy at BTIG Research)
  • MOMO +1.1% (initiated with a Buy at Jefferies)
  • PNC +0.8% (added to Conviction Buy List at Goldman)